Atlas Trials

Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age

Clinical trial NCT03204227 · COMPLETED

Trial details

NCT number
NCT03204227
Sponsor
National Institute of Hygiene and Epidemiology, Vietnam
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Japanese Encephalitis
Start date
2017-06-02
Primary completion
2017-08-12
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.